# Influence of NEP Inhibition on Vascular Leak and Inflammation (NEPi-INFLAMMATION)

> **NCT05600062** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Queen Mary University of London** · enrollment: 48 (estimated)

## Conditions studied

- Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** Racecadotril 100 milligram (MG) Oral Capsule
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05600062
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-03-21
- **Primary completion:** 2026-02-01
- **Final completion:** 2026-06-15
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05600062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05600062, "Influence of NEP Inhibition on Vascular Leak and Inflammation (NEPi-INFLAMMATION)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05600062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*